Key Market Indicators
Icelander analgesic medicine sales are projected to reach $9.34 million by 2026, a 1% increase from 2021. Since 1994, the country’s market has grown an average of 4.6% annually. Icelander stood at number 25 in 2021, with Estonia ahead at $9.02 million. Spain, Canada and Italy followed, coming in at numbers two, three and four, respectively.
